Form 4 for NKTR NEKTAR THERAPEUTICS

Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-22 · accession 0001209191-21-057703 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-09-24	2021-09-22	NKTR	CHESS ROBERT	Dir	A - Grant	$0.00	+10.2K	284.5K	+4%	$0
D	2021-09-24	2021-09-22	NKTR	CHESS ROBERT	Dir	S - Sale	$17.94	-4,600	279.9K	-2%	-$82.5K
D	2021-09-24	2021-09-22	NKTR	CHESS ROBERT	Dir	A - Grant	$0.00	+20.4K	20.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-09-22	A	A	10,200	$0.00	284,473	D	—	—	(F1) Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
2	Common	Common Stock	2021-09-22	S	D	4,600	$17.94	279,873	D	—	—	(F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. (F4) This transaction was executed in multiple trades at prices ranging from $17.59 to $18.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issues.
3	Derivative	Stock Option	2021-09-22	A	A	20,400	$0.00	20,400	D	$17.78 · — to 2029-09-21	20,400 Common Stock	(F6) This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2021.